Le Lézard
Classified in: Health, Science and technology, Business
Subject: DIV

Danaher Announces Quarterly Dividend


WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 26, 2024 to holders of record on March 28, 2024.

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

SOURCE Danaher Corporation


These press releases may also interest you

at 06:17
Local Infusion Opens Infusion Center in New Haven, Connecticut, the Seventh Location to Open in New England
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

at 06:05
Revvity Announces Financial Results for the First Quarter of 2024
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:00
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Repertoire® Immune...

at 06:00
Akoya Pediatric Dentistry in Southwest Ranches, FL Launches New Website
Akoya Pediatric Dentistry is excited to announce the launch...

at 06:00
Quincy Family Orthodontics Launches New Website to Enhance Patient Experience
Quincy Family Orthodontics is excited to announce the launch of its new website, https://www.quincyfamilyortho.com, as well as its new office location at 300 Crown Colony Drive, Suite #205 in Quincy, MA. At our clinic, the patient comes first...

More news about Health...


News published on and distributed by: